|Description||(R)-3,4-DCPG is an AMPA receptor antagonist with weak activity at NMDA receptors and no activity at kainate receptors.|
|Brife Description||AMPA receptor antagonist|
|Purity||≥96% by HPLC|
|Related CAS||176796-64-8 (racemic mixture)|
|Synonyms||(R)-3,4-Dicarboxyphenylglycine; 4-[(1R)-1-Amino-2-hydroxy-2-oxoethyl]phthalic acid|
GYKI-53784, a dioxolbenzene derivative, has been found to be a AMPA receptor antagonist that could block excitotoxicity and decrease auditory nerve activity at ...
YM 90K hydrochloride
YM 90K hydrochloride is a selective AMPA receptor antagonist (Ki = 84, 2200 and > 37000 nM for AMPA, kainate and NMDA receptors, respectively). YM 90K hydrochlo...
2,6-Difluoro-4-[2-(phenylsulfonylamino)ethylthio]phenoxyacetamide is a structurally novel, selective, high affinity AMPA ionotropic glutamate receptor ag...
(RS)-AMPA has been found to be a definitive agonist of the AMPA glutamatergic ionotropic receptor.
Incubation of LY451395 with Actinoplanes missouriensis NRRL B3342 generated several metabolites that were previously detected in the in vivo metabolism studies ...
JNJ 55511118 has been found to be an AMPA receptor modulator and could probably be used as an anticonvulsant.
Talampanel, also known as LY300164 and GYKI-53773, is a glutamate receptor inhibitor with anti-seizure activity. Talampanel is also an orally active, potent an...
UBP 282 is an AMPA and kainate receptor antagonist. UBP 282 inhibits AMPA receptor-, but not kainate receptor-mediated currents on spinal neonatal motoneurons y...